| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.38 | 0.04 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |